Welcome to Galveston National Laboratory

Statement from GNL Leadership on Hurricane Harvey
August 31, 2017

"There are inaccurate reports that the Galveston National Laboratory (GNL) at The University of Texas Medical Branch at Galveston may have been compromised because of Hurricane Harvey. These false reports do a disservice to all of the people in our community and the dedicated scientists and workers on staff at the GNL.

The laboratory, which researches and develops diagnostics and treatments for infectious diseases, was built to withstand hurricane conditions and has emergency procedures in place to ensure safe operations and preservation of research at all times.

The GNL reported that the facility continued operations without interruption and did not incur any damage, loss of power or biocontainment during the storm. At no time was there cause of concern for the safety and security of GNL personnel, the research or the community."

Further information is available in an article available on the Galveston County Daily News website: Rumor Control: Galveston's National Laboratory is Fine

 

Within this state-of-the-art facility, an extraordinary group of scientists are engaged in efforts to translate research ideas into products aimed at controlling emerging infectious diseases and defending our society against bioterrorism. The GNL has been designed to serve as a national resource, and will complement and enhance UTMB's decades of prominence in biomedical research - as well as provide a world renowned resource for training researchers in infectious diseases.

 

As one of two National Biocontainment Laboratories constructed with funding awarded in October 2003 by the National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH), the GNL provides much needed research space and specialized research capabilities to develop therapies, vaccines, and diagnostic tests for naturally occurring emerging diseases such as SARS, West Nile encephalitis and avian influenza – as well as for microbes that might be employed by terrorists. Products likely to emerge from research and investigations within the GNL include novel diagnostic assays, improved therapeutics and treatment models, and preventative measures such as vaccines.

 

Construction Update


UTMB and FDA Educational Collaboration: Academic Development of a Training Program for Good Laboratory Practices in High Containment Environments

The FDA and UTMB have collaborated on this new course which will take place April 24 - 28, 2017, at the National Institutes of Health in Bethesda, Maryland.

Click here for more information.


Visit our News page for information on some of the exciting research being conducted in the GNL.